Novel antibacterial agents for the treatment of serious Gram-positive infections

Darren Abbanat, Mark Macielag, Karen Bush
  • Expert Opinion on Investigational Drugs, March 2003, Informa Healthcare
  • DOI: 10.1517/13543784.12.3.379

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/13543784.12.3.379

The following have contributed to this page: Dr. Karen Bush